TIAA CREF Investment Management LLC Lowers Stake in National Health Investors, Inc. (NHI)
TIAA CREF Investment Management LLC lowered its position in National Health Investors, Inc. (NYSE:NHI) by 3.5% during the third quarter, Holdings Channel reports. The fund owned 148,887 shares of the real estate investment trust’s stock after selling 5,363 shares during the period. TIAA CREF Investment Management LLC’s holdings in National Health Investors were worth $11,685,000 as of its most recent SEC filing.
Several other hedge funds have also recently modified their holdings of NHI. BlackRock Fund Advisors boosted its stake in shares of National Health Investors by 26.9% in the third quarter. BlackRock Fund Advisors now owns 1,252,512 shares of the real estate investment trust’s stock worth $98,297,000 after buying an additional 265,679 shares during the last quarter. UBS Asset Management Americas Inc. boosted its stake in shares of National Health Investors by 4.5% in the third quarter. UBS Asset Management Americas Inc. now owns 61,683 shares of the real estate investment trust’s stock worth $4,841,000 after buying an additional 2,665 shares during the last quarter. Adams Diversified Equity Fund Inc. purchased a new stake in shares of National Health Investors during the second quarter worth about $466,000. Bank of New York Mellon Corp boosted its stake in shares of National Health Investors by 7.5% in the third quarter. Bank of New York Mellon Corp now owns 340,641 shares of the real estate investment trust’s stock worth $26,733,000 after buying an additional 23,668 shares during the last quarter. Finally, BlackRock Advisors LLC boosted its stake in shares of National Health Investors by 12.3% in the second quarter. BlackRock Advisors LLC now owns 28,255 shares of the real estate investment trust’s stock worth $2,122,000 after buying an additional 3,104 shares during the last quarter. Institutional investors and hedge funds own 71.20% of the company’s stock.
National Health Investors, Inc. (NYSE:NHI) opened at 73.55 on Friday. The company’s 50-day moving average price is $73.01 and its 200 day moving average price is $75.90. National Health Investors, Inc. has a 52-week low of $54.51 and a 52-week high of $82.53. The firm has a market capitalization of $2.93 billion, a price-to-earnings ratio of 17.23 and a beta of 0.60.
National Health Investors (NYSE:NHI) last posted its earnings results on Monday, November 7th. The real estate investment trust reported $1.23 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.25 by $0.02. National Health Investors had a net margin of 68.03% and a return on equity of 14.12%. The business earned $63.30 million during the quarter, compared to analyst estimates of $62.39 million. During the same period in the previous year, the firm posted $1.07 earnings per share. The firm’s revenue was up 8.6% on a year-over-year basis. Equities research analysts predict that National Health Investors, Inc. will post $3.71 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 31st. Shareholders of record on Friday, December 30th will be paid a $0.90 dividend. The ex-dividend date is Wednesday, December 28th. This represents a $3.60 dividend on an annualized basis and a yield of 4.89%. National Health Investors’s payout ratio is 84.11%.
ILLEGAL ACTIVITY WARNING: This news story was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this news story can be viewed at http://www.watchlistnews.com/tiaa-cref-investment-management-llc-lowers-stake-in-national-health-investors-inc-nhi/1061279.html.
A number of analysts have recently issued reports on NHI shares. Zacks Investment Research upgraded National Health Investors from a “hold” rating to a “buy” rating and set a $84.00 target price for the company in a report on Tuesday, October 11th. Cantor Fitzgerald set a $75.00 price target on National Health Investors and gave the stock a “hold” rating in a research report on Thursday, November 10th. Six investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $75.33.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI).
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.